Electronic Symptom Management for Advanced Cancer
Trial Summary
What is the purpose of this trial?
This trial is testing Nurse AMIE 3.0, a tablet-based program, to help stage 3 and 4 cancer patients in rural areas manage their symptoms. The program aims to provide remote support to improve their overall survival.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current treatments, as the trial focuses on managing symptoms electronically.
What data supports the effectiveness of the treatment Nurse AMIE for advanced cancer?
Research shows that nurse practitioners, when involved in supportive interventions like home visits, can significantly improve pain control and quality of life for patients with advanced cancer. This suggests that treatments involving nurse-led care, like Nurse AMIE, may be effective in managing symptoms and improving patient outcomes.12345
How is the Nurse AMIE treatment different from other treatments for advanced cancer?
Research Team
Kathryn Schmitz, PhD
Principal Investigator
University of Pittsburgh / UPMC
Eligibility Criteria
This trial is for adults with advanced stage 3 or 4 cancer, living in certain rural areas, who are undergoing treatment (not just palliative care). They must have a life expectancy of at least 6 months, be able to use a phone for check-ins, and not be part of other supportive care studies.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Measurements
Participants complete baseline measurements after informed consent
Treatment
Participants are randomly assigned to receive either the Nurse AMIE program or a supportive care book
Follow-up
Participants are monitored for survival and other outcomes after treatment
Treatment Details
Interventions
- Nurse AMIE
- Usual Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Milton S. Hershey Medical Center
Lead Sponsor
University of Pittsburgh
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
West Virginia University
Collaborator
Mount Nittany Medical Center
Collaborator
Penn State University
Collaborator